EGFR and posterior cortical atrophy: Different inhibitors against EGFR, like Erlotinib, Gefitinib, Vandetanib (which additionally inhibits VEGF), and Lapatinib (which additionally inhibits HER2) were tested alone or in combination with chemotherapy in phase II studies on patients with castration resistant PCa [24,25,26,27].